13.3%; P = 0.216) were observed in the RAS blocker group, although these differences failed to reach statistical significance.
← all excerpts
Renin-angiotensin system blockers and severe acute respiratory syndrome coronavirus 2.
1
—
—
13.3%; P = 0.216) were observed in the RAS blocker group, although these differences failed to reach statistical significance.